Lineage Cell Therapeutics, Inc. (LCTX)
1.025
+0.08
(+8.17%)
USD |
NYAM |
Oct 08, 16:00
1.025
0.00 (0.00%)
After-Hours: 19:31
Lineage Cell Therapeutics Max Drawdown (5Y) : 87.55% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 87.55% |
| August 31, 2026 | 87.55% |
| July 31, 2026 | 87.55% |
| June 30, 2026 | 87.55% |
| May 31, 2026 | 87.55% |
| April 30, 2026 | 87.55% |
| March 31, 2026 | 87.55% |
| February 28, 2026 | 87.55% |
| January 31, 2026 | 87.55% |
| December 31, 2025 | 87.55% |
| November 30, 2025 | 87.55% |
| October 31, 2025 | 87.55% |
| September 30, 2025 | 87.55% |
| August 31, 2025 | 87.55% |
| July 31, 2025 | 87.55% |
| June 30, 2025 | 87.55% |
| May 31, 2025 | 87.55% |
| April 30, 2025 | 87.55% |
| March 31, 2025 | 86.74% |
| February 28, 2025 | 88.95% |
| January 31, 2025 | 88.95% |
| December 31, 2024 | 88.95% |
| November 30, 2024 | 90.06% |
| October 31, 2024 | 90.06% |
| September 30, 2024 | 90.06% |
| Date | Value |
|---|---|
| August 31, 2024 | 90.06% |
| July 31, 2024 | 90.06% |
| June 30, 2024 | 90.06% |
| May 31, 2024 | 90.06% |
| April 30, 2024 | 90.06% |
| March 31, 2024 | 90.06% |
| February 29, 2024 | 90.06% |
| January 31, 2024 | 90.06% |
| December 31, 2023 | 90.06% |
| November 30, 2023 | 90.06% |
| October 31, 2023 | 90.06% |
| September 30, 2023 | 90.06% |
| August 31, 2023 | 90.06% |
| July 31, 2023 | 90.06% |
| June 30, 2023 | 90.06% |
| May 31, 2023 | 90.06% |
| April 30, 2023 | 90.06% |
| March 31, 2023 | 90.06% |
| February 28, 2023 | 90.06% |
| January 31, 2023 | 90.06% |
| December 31, 2022 | 90.06% |
| November 30, 2022 | 90.06% |
| October 31, 2022 | 90.06% |
| September 30, 2022 | 90.06% |
| August 31, 2022 | 90.06% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |
| Imunon, Inc. | 99.49% |
| Curis, Inc. | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -37.42 |
| Beta (5Y) | 1.600 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 60.46% |
| Historical Sharpe Ratio (5Y) | -0.3542 |
| Historical Sortino (5Y) | -0.6803 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.82% |